Alibhai Imran Nizamudin bought TVRD

January 29, 2026 · Form 4 insider transaction

Alibhai Imran Nizamudin bought 115,000 shares of Tvardi Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
115,000
Price
$0.00
Total value
N/A
RoleOfficer, Director
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 29, 2026
Filing dateFebruary 2, 2026
Shares owned after115,000
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The shares subject to the option shall vest and become exercisable in equal monthly installments over 48 months commencing on January 29, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

View the original Form 4 on SEC EDGAR